Benjafield AV, Ayas NT, Eastwood PR, Heinzer R, Ip MSM, Morrell MJ, et al. Estimation of the global prevalence and burden of obstructive sleep apnoea: a literature-based analysis. Lancet Respir Med. 2019;7:687–98.
Google Scholar
Almendros I, Martinez-Garcia MA, Farré R, Gozal D. Obesity, sleep apnea, and cancer. Int J Obes. 2020;44:1653–67.
Google Scholar
Gozal D, Ham SA, Mokhlesi B. Sleep apnea and cancer: analysis of a nationwide population sample. Sleep. 2016;39:1493–500.
Google Scholar
Almendros I, Gozal D. Intermittent hypoxia and cancer: undesirable bed partners?. Respir Physiol Neurobiol. 2018;256:79–86.
Google Scholar
Hazelwood E, Goudswaard LJ, Lee MA, Vabistsevits M, Pournaras DJ, Brenner H, et al. Adiposity distribution and risks of 12 obesity-related cancers: a Mendelian randomization analysis. J Natl Cancer Inst. 2025;117:2621–42.
Hajipour M, Hu W-H, Esmaeili N, Sands S, Wellman A, Kwon Y, et al. Sleep apnea physiological burdens and markers of white matter injury: the Multi-Ethnic Study of Atherosclerosis. J Clin Sleep Med. 2025;21:457–66.
Google Scholar
Esmaeili N, Labarca G, Hu W-H, Vena D, Messineo L, Gell L, et al. Hypoxic burden based on automatically identified desaturations is associated with adverse health outcomes. Ann Am Thorac Soc. 2023;20:1633–41.
Google Scholar
Azarbarzin A, Vena D, Esmaeili N, Wellman A, Pinilla L, Messineo L, et al. Cardiovascular benefit of continuous positive airway pressure according to high-risk obstructive sleep apnoea: a multi-trial analysis. Eur Heart J. 2026;47:2077–89.
Labarca G, Vena D, Hu W-H, Esmaeili N, Gell L, Yang HC, et al. Sleep apnea physiological burdens and cardiovascular morbidity and mortality. Am J Respir Crit Care Med. 2023;208:802–13.
Google Scholar
Martinez-Garcia MA, Sánchez-de-la-Torre M, White DP, Azarbarzin A. Hypoxic burden in obstructive sleep apnea: present and future. Archivos De Bronconeumología. 2022;59:36–43.
Google Scholar
Tan BKJ, Teo YH, Tan NKW, Yap DWT, Sundar R, Lee CH, et al. Association of obstructive sleep apnea and nocturnal hypoxemia with all-cancer incidence and mortality: a systematic review and meta-analysis. J Clin Sleep Med. 2022;18:1427–40.
Google Scholar
Griffin W, Roux CW, le, Heneghan HM, O’Shea D, Garvey JF. The role of weight management in sleep disordered breathing. Breathe. 2025;21:250182.
Google Scholar
O’Donnell C, King A, Vial G, O’Neill E, Crilly S, Dodd JD, et al. Effect of liraglutide on intermittent hypoxia-induced metabolic dysfunction: from bench to bedside. J Sleep Res. 2026;35:e70152.
Bardóczi A, Matics ZZ, Turan C, Szabó B, Molnár Z, Hegyi P, et al. Efficacy of incretin-based therapies in obesity-related obstructive sleep apnea: a systematic review and meta-analysis of randomized controlled trials. Sleep Med Rev. 2025;82:102119.
Google Scholar
Valencia-Rincón E, Rai R, Chandra V, Wellberg EA. GLP-1 receptor agonists and cancer: current clinical evidence and translational opportunities for preclinical research. J Clin Investig. 2025;135:e194743.
Google Scholar
Renehan AG, Zwahlen M, Egger M. Adiposity and cancer risk: new mechanistic insights from epidemiology. Nat Rev Cancer. 2015;15:484–98.
Google Scholar
Lamabadusuriya DA, Jayasena H, Bopitiya AK, Silva ADD, Jayasekera P. Obesity-driven inflammation and cancer risk: a comprehensive review. Semin Cancer Biol. 2025;114:256–66.
Google Scholar
Leitzmann MF, Stein MJ, Baurecht H, Freisling H. Excess adiposity and cancer: evaluating a preclinical-clinical obesity framework for risk stratification. eClinicalMedicine. 2025;83:103247.
Google Scholar
Pasarica M, Sereda OR, Redman LM, Albarado DC, Hymel DT, Roan LE, et al. Reduced adipose tissue oxygenation in human obesity: evidence for rarefaction, macrophage chemotaxis, and inflammation without an angiogenic response. Diabetes. 2008;58:718–25.
Google Scholar
Markina NO, Matveev GA, Zasypkina KA, Khromova NV, Babenko AYU, Shlyakhto EV. Comparative analysis of gene and microRNA expression in subcutaneous adipose tissue in metabolically healthy and unhealthy obesity. Int J Mol Sci. 2025;26:8212.
Google Scholar
Otandault A, Abraham J-D, Dache ZAA, Khalyfa A, Jariel-Encontre I, Forné T, et al. Hypoxia differently modulates the release of mitochondrial and nuclear DNA. Br J Cancer. 2020;122:715–25.
Google Scholar
Meliante PG, Zoccali F, Cascone F, Stefano VD, Greco A, Vincentiis M, et al. Molecular pathology, oxidative stress, and biomarkers in obstructive sleep apnea. Int J Mol Sci. 2023;24:5478.
Google Scholar
Sillah A, Watson NF, Schwartz SM, Gozal D, Phipps AI. Sleep apnea and subsequent cancer incidence. Cancer Causes Control. 2018;29:987–94.
Google Scholar
Gozal D, Almendros I, Phipps AI, Campos-Rodriguez F, Martínez-García MA, Farré R. Sleep apnoea adverse effects on cancer: true, false, or too many confounders?. Int J Mol Sci. 2020;21:8779.
Google Scholar
Cao Y, Ning P, Li Q, Wu S. Cancer and obstructive sleep apnea: an updated meta-analysis. Medicine. 2022;101:e28930.
Google Scholar
Cubillos-Zapata C, Almendros I, Díaz-García E, Toledano V, Casitas R, Galera R, et al. Differential effect of intermittent hypoxia and sleep fragmentation on PD-1/PD-L1 upregulation. Sleep. 2019;43:zsz285.
Google Scholar
Díaz-García E, García-Sánchez A, Alfaro E, López-Fernández C, Mañas E, Cano-Pumarega I, et al. PSGL-1: a novel immune checkpoint driving T-cell dysfunction in obstructive sleep apnea. Front Immunol. 2023;14:1277551.
Google Scholar
Recoquillon S, Ali S, Justeau G, Riou J, Martinez MC, Andriantsitohaina R, et al. Small extracellular vesicles harboring PD-L1 in obstructive sleep apnea. Int J Mol Sci. 2024;25:3208.
Google Scholar
Díaz-García E, García-Sánchez A, Alfaro E, López-Fernández C, Mañas E, Casitas R, et al. Dysregulation in CD39/CD73 axis may trigger the upsurge of the immune suppressive agent adenosine in OSA patients. Arch Bronconeumol. 2024;60:207–14.
Google Scholar
Almendros I, Gileles-Hillel A, Khalyfa A, Wang Y, Zhang SX, Carreras A, et al. Adipose tissue macrophage polarization by intermittent hypoxia in a mouse model of OSA: effect of tumor microenvironment. Cancer Lett. 2015;361:233–9.
Google Scholar
Cubillos-Zapata C, Martínez-García MÁ, Díaz-García E, García-Tovar S, Campos-Rodríguez F, Sánchez-de-la-Torre M, et al. Obstructive sleep apnoea is related to melanoma aggressiveness through paraspeckle protein-1 upregulation. Eur Respir J. 2022;61:2200707.
Google Scholar
Carreres L, Mercey-Ressejac M, Kurma K, Ghelfi J, Fournier C, Manches O, et al. Chronic intermittent hypoxia increases cell proliferation in hepatocellular carcinoma. Cells. 2022;11:2051.
Google Scholar
Almendros I, Montserrat JM, Torres M, Bonsignore MR, Chimenti L, Navajas D, et al. Obesity and intermittent hypoxia increase tumor growth in a mouse model of sleep apnea. Sleep Med. 2012;13:1254–60.
Google Scholar
He X, Ye X, Yang K, Li Z. Causal associations of obstructive sleep apnea with cancer risk: a Mendelian randomization study. Brain Behav. 2025;15:e70462.
Google Scholar
Díaz-García E, Alfaro E, Pérez-Moreno P, López-Fernández C, García-Sánchez A, Martínez-García MÁ, et al. Immune checkpoint biomarkers galectin-9 and TIM-3 predict melanoma and lung cancer mortality in obstructive sleep apnoea. Arch Bronconeumol. 2025. https://doi.org/10.1016/j.arbres.2025.03.018.
Figueroa F, Liu E, Schulte P, Escalante P, Lim K, Peikert T, et al. Lung cancer reoccurrence and mortality is accelerated with episodic hypoxemia. Respir Med. 2025;247:108303.
Google Scholar
Claesson M, Franklin O, Sund M, Blomberg A, Lindberg E, Svensson J, et al. Self-reported witnessed episodes of apnea during sleep is associated with incident lung and breast cancer. Sleep Med. 2025;133:106567.
Google Scholar
Proesmans K, Luik AI, Lahousse L. Sex-specific associations between sleep apnoea and lung cancer risk in patients with COPD: a nationwide prospective cohort study. Lancet Reg Health Eur. 2025;52:101269.
Google Scholar
Lin M, Abuduxukuer K, Ye L, Zhang H, Zhang X, Shi S, et al. Association between the nutritional inflammatory index and obstructive sleep apnea risk: insights from the NHANES 2015–2020 and Mendelian randomization analyses. Healthcare. 2025;13:783.
Google Scholar
Yao J, Duan R, Li Q, Mo R, Zheng P, Feng T. Association between obstructive sleep apnea and risk of lung cancer: findings from a collection of cohort studies and Mendelian randomization analysis. Front Oncol. 2024;14:1346809.
Google Scholar
Wang M. Obesity promotes tumour growth by boosting PD1 levels on macrophages. Nat Rev Nephrol. 2024;20:567–567.
Google Scholar
Glenny EM, Lin T, Bandera VM, Mirminachi B, Khumukcham SS, Gigic B, et al. Obesity promotes conserved inflammatory and metabolic transcriptional programs in colon tumors: evidence from mouse models and the ColoCare Study Patient Cohort. Am J Clin Nutr. 2025;122:1545–56.
Google Scholar
Hopkins BD, Goncalves MD, Cantley LC. Obesity and cancer mechanisms: cancer metabolism. J Clin Oncol. 2016;34:4277–83.
Google Scholar
Gómez-Olivas JD, Campos-Rodriguez F, Nagore E, Martorell A, García-Rio F, Cubillos C, et al. Role of sleep apnea and long-term CPAP treatment in the prognosis of patients with melanoma a prospective multicenter study of 443 patients. Chest. 2023;164:1551–9.
Google Scholar
Liao C, Schapiro D, Mojdami D, Sheffield KM, Hoog MM, Keni R, et al. Intentional weight loss and associated cancer incidence among people with overweight or obesity: a systematic literature review. Endocrinol Diabetes Metab. 2025;8:e70104.
Google Scholar
Stenberg E, Ottosson J, Cao Y, Lagstam I, Näslund E. Risk for cancer after bariatric surgery compared with the general population: a nationwide matched cohort study. Obesity. 2025;33:1725–33.
Google Scholar
Bulsei J, Carandina S, Zulian V, Fontas E, Iannelli A. Metabolic and bariatric surgery reduces the risk of hematological cancer in individuals with obesity: a nationwide administrative data study in France. Int J Surg. 2025;111:6970–7.
Google Scholar
Goyal A, Macias CA, Corzo MP, Tomey D, Shetty S, Peña V, et al. Outcomes of metabolic and bariatric surgery in populations with obesity and their risk of developing colorectal cancer: where do we stand? An umbrella review on behalf of TROGSS—The Robotic Global Surgical Society. Cancers. 2025;17:670.
Google Scholar
Malhotra A, Grunstein RR, Fietze I, Weaver TE, Redline S, Azarbarzin A, et al. Tirzepatide for the treatment of obstructive sleep apnea and obesity. N Engl J Med. 2024;391:1193–205.
Google Scholar
Jastreboff AM, Aronne LJ, Ahmad NN, Wharton S, Connery L, Alves B, et al. Tirzepatide once weekly for the treatment of obesity. N Engl J Med. 2022;387:205–16.
Google Scholar
Tirzepatide for the treatment of obstructive sleep apnea and obesity. N Engl J Med. 2024;391:1464.
Schneider L. GLP-1 drugs associated with lower overall cancer risk. JAMA. 2025;334:1224.
Google Scholar
Dai H, Li Y, Lee YA, Lu Y, George TJ, Donahoo WT, et al. GLP-1 receptor agonists and cancer risk in adults with obesity. JAMA Oncol. 2025;11:1186–93.
Google Scholar
Wu C-C, Su C-C, Chang Y-C, Lee P-T, Su Y-C. Reduced risks of colorectal cancer with GLP-1RAs in type 2 diabetes: a nationwide cohort study using a target trial emulation framework. Diabetes Metab. 2025;51:101695.
Google Scholar
Mao X, Zhang X, Henry L, Cheung KS, Yuen M-F, Cheung R, et al. Association between glucagon-like peptidase 1 receptor agonist and obesity-related cancer in overweight or obese patients with type 2 diabetes: a nationwide cohort study. J Natl Cancer Inst. 2025;117:2053–61.
Google Scholar
Hung C-M, Zeng B-Y, Hsu C-W, Chen P-H, Sun C-K, Carvalho AF, et al. The different colorectal tumor risk related to GLP-1 receptor agonists and SGLT2 inhibitors use: a network meta-analysis of 68 randomized controlled trials. Int J Surg. 2025. https://doi.org/10.1097/js9.0000000000003450.
Lu Y, Dai H, Tang H, Donahoo WT, George TJ, Sun RC, et al. Association of glucagon-like peptide-1 receptor agonists with cancer risk in older adults with type 2 diabetes. Obesity. 2025. https://doi.org/10.1002/oby.24366.
Malhotra A, Ayappa I, Ayas N, Collop N, Kirsch D, Mcardle N, et al. Metrics of sleep apnea severity: beyond the apnea-hypopnea index. Sleep. 2021;44:zsab030.
Google Scholar
Liu H, Fu H, Wang Z, Yao Z, Wang Q, Sui A, et al. The predictive value of a body shape index as a novel obesity metric for cancer risk: a systematic review and meta-analysis. Front Nutr. 2025;12:1667466.
Google Scholar
Sibal R, Balamurugan G, Graham Y, Mahawar K. Moving away from BMI: a new era of diagnostic criteria in obesity. Expert Rev Endocrinol Metab. 2025;20:403–13.
Google Scholar
Ren J, Jin Z, Huang Y. Exosomal miR-106a-5p derived from intermittently hypoxic non-small-cell lung cancer increases tumor malignancy. Physiol Rep. 2024;12:e16157.
Google Scholar
Khalyfa A, Masa JF, Qiao Z, González M, Marti S, Khalyfa AA, et al. Plasma exosomes in obesity hypoventilation syndrome patients drive lung cancer cell malignant properties: effect of long-term adherent CPAP treatment. Biochim Biophys Acta Mol Basis Dis. 2022;1868:166479.
Google Scholar
Khalyfa A, Trzepizur W, Gileles-Hillel A, Qiao Z, Sanz-Rubio D, Marin JM, et al. Heterogeneity of melanoma cell responses to sleep apnea-derived plasma exosomes and to intermittent hypoxia. Cancers. 2021;13:4781.
Google Scholar
